AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

List of Sentri7 Drug Diversion Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Old Product New Product Category When SI
Aultman Health Insurance 7000 $2.0B United States Wolters Kluwer Legacy Sentri7 Drug Diversion Pharmacy Management 2015 n/a
Mary Lanning Healthcare Healthcare 500 $65M United States Wolters Kluwer Legacy Sentri7 Drug Diversion Pharmacy Management 2023 n/a
Piedmont Athens Regional Healthcare 3300 $460M United States Wolters Kluwer Legacy Sentri7 Drug Diversion Pharmacy Management 2025 n/a
Healthcare 31000 $6.0B United States Wolters Kluwer Legacy Sentri7 Drug Diversion Pharmacy Management 2017 n/a
Showing 1 to 4 of 4 entries

Buyer Intent: Companies Evaluating Sentri7 Drug Diversion

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Sentri7 Drug Diversion. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Sentri7 Drug Diversion Coverage

Sentri7 Drug Diversion is a Pharmacy Management solution from Wolters Kluwer.

Companies worldwide use Sentri7 Drug Diversion, from small firms to large enterprises across 21+ industries.

Organizations such as Piedmont Augusta, Aultman Health, Piedmont Athens Regional and Mary Lanning Healthcare are recorded users of Sentri7 Drug Diversion for Pharmacy Management.

Companies using Sentri7 Drug Diversion are most concentrated in Healthcare and Insurance, with adoption spanning over 21 industries.

Companies using Sentri7 Drug Diversion are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Sentri7 Drug Diversion across Americas, EMEA, and APAC.

Companies using Sentri7 Drug Diversion range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 25%, large organizations with 1,001-10,000 employees - 50%, and global enterprises with 10,000+ employees - 25%.

Customers of Sentri7 Drug Diversion include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Sentri7 Drug Diversion customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Pharmacy Management.